{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:25:47Z","timestamp":1780727147290,"version":"3.54.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02591"],"award-info":[{"award-number":["18H02591"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26713006"],"award-info":[{"award-number":["26713006"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240216","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T17:56:53Z","timestamp":1602179813000},"page":"e0240216","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma"],"prefix":"10.1371","volume":"15","author":[{"given":"Shunsuke","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-0056","authenticated-orcid":true,"given":"Toru","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kanemaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosei","family":"Minoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihisa","family":"Orita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7977-7597","authenticated-orcid":true,"given":"Hirofumi","family":"Jono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"pone.0240216.ref001","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.otc.2006.08.003","article-title":"The pathophysiology of cholesteatoma","volume":"39","author":"MT Semaan","year":"2006","journal-title":"Otolaryngol Clin North Am"},{"key":"pone.0240216.ref002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00405-003-0623-x","article-title":"Etiopathogenesis of cholesteatoma","volume":"261","author":"E Olszewska","year":"2004","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"pone.0240216.ref003","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1017\/S0022215113000601","article-title":"Acquired cholesteatoma: summary of the cascade of molecular events","volume":"127","author":"L Louw","year":"2013","journal-title":"J Laryngol Otol"},{"key":"pone.0240216.ref004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3342\/ceo.2008.1.3.117","article-title":"The role of inflammatory mediators in the pathogenesis of otitis media and sequelae","volume":"1","author":"SK Juhn","year":"2008","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"pone.0240216.ref005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1017\/S0022215109992763","article-title":"Acquired cholesteatoma pathogenesis: Stepwise explanations","volume":"124","author":"L. Louw","year":"2010","journal-title":"J Laryngol Otol"},{"key":"pone.0240216.ref006","first-page":"854024","article-title":"Updates and knowledge gaps in cholesteatoma research","volume":"2015","author":"CL Kuo","year":"2015","journal-title":"Biomed Res Int"},{"key":"pone.0240216.ref007","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1288\/00005537-198609000-00002","article-title":"Cholesteatoma Staging","volume":"96","author":"WL Meyerhoff","year":"1986","journal-title":"Laryngoscope"},{"key":"pone.0240216.ref008","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2273.1999.00272.x","article-title":"Classification and Staging of Cholesteatoma","volume":"24","author":"HA Saleh","year":"1999","journal-title":"Clin. Otolaryngol. Allied. Sci"},{"key":"pone.0240216.ref009","first-page":"611","article-title":"Cholesteatoma staging system","volume":"18","author":"Japan Otological Society","year":"2008","journal-title":"Otology Japan"},{"key":"pone.0240216.ref010","first-page":"30","article-title":"Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications","volume":"19","author":"AP Albino","year":"1998","journal-title":"Am J Otol"},{"key":"pone.0240216.ref011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000094377","article-title":"Cell cycle inhibitory protein p27 in human middle ear cholesteatoma","volume":"68","author":"J Kuczkowski","year":"2006","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"pone.0240216.ref012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/76006","article-title":"Identification of the familial cylindromatosis tumour-suppressor gene","volume":"25","author":"GR Bignell","year":"2000","journal-title":"Nat Genet"},{"key":"pone.0240216.ref013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cdd.2009.43","article-title":"CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes","volume":"17","author":"SC Sun","year":"2010","journal-title":"Cell Death Differ"},{"key":"pone.0240216.ref014","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination","volume":"424","author":"A Kovalenko","year":"2003","journal-title":"Nature"},{"key":"pone.0240216.ref015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature01803","article-title":"CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members","volume":"424","author":"E Trompouki","year":"2003","journal-title":"Nature"},{"key":"pone.0240216.ref016","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature01811","article-title":"Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB","volume":"424","author":"TR Brummelkamp","year":"2003","journal-title":"Nature"},{"key":"pone.0240216.ref017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/carcin\/bgl081","article-title":"Reduced expression of CYLD in human colon and hepatocellular carcinomas","volume":"28","author":"C Hellerbrand","year":"2007","journal-title":"Carcinogenesis"},{"key":"pone.0240216.ref018","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20082044","article-title":"Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma","volume":"206","author":"R Massoumi","year":"2009","journal-title":"J Exp Med"},{"key":"pone.0240216.ref019","first-page":"121","article-title":"Down-regulation of CYLD as a trigger for NF-\u03baB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells","volume":"38","author":"T Urbanik","year":"2011","journal-title":"Int J Oncol"},{"key":"pone.0240216.ref020","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1038\/onc.2011.163","article-title":"GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma","volume":"30","author":"S Kuphal","year":"2011","journal-title":"Oncogene"},{"key":"pone.0240216.ref021","first-page":"53","article-title":"Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity","volume":"41","author":"Y Ishikawa","year":"2012","journal-title":"Int J Oncol"},{"key":"pone.0240216.ref022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3892\/mco.2013.68","article-title":"CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma","volume":"1","author":"H Kinoshita","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"pone.0240216.ref023","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-013-2824-3","article-title":"Clinical significance of CYLD downregulation in breast cancer","volume":"143","author":"M Hayashi","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0240216.ref024","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.18632\/oncotarget.2216","article-title":"Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy","volume":"5","author":"J Guo","year":"2014","journal-title":"Oncotarget"},{"key":"pone.0240216.ref025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.5019","article-title":"Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma","volume":"244","author":"S Shinriki","year":"2018","journal-title":"J Pathol"},{"key":"pone.0240216.ref026","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1371\/journal.pone.0001032","article-title":"Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice","volume":"2","author":"J Lim","year":"2007","journal-title":"PLoS One"},{"key":"pone.0240216.ref027","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/00016489609137846","article-title":"Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas","volume":"116","author":"CS Kim","year":"1996","journal-title":"Acta Otolaryngol"},{"key":"pone.0240216.ref028","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00129492-200209000-00007","article-title":"Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma","volume":"23","author":"S Yetiser","year":"2002","journal-title":"Otol Neurotol"},{"key":"pone.0240216.ref029","first-page":"350","article-title":"Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear","volume":"13","author":"V Schilling","year":"1992","journal-title":"Am J Otol"},{"key":"pone.0240216.ref030","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1038\/cddis.2011.82","article-title":"CYLD regulates keratinocyte differentiation and skin cancer progression in humans","volume":"2","author":"JP Alameda","year":"2011","journal-title":"Cell Death Dis"},{"key":"pone.0240216.ref031","first-page":"796315","article-title":"Expression of CYLD and NF-kappaB in human cholesteatoma epithelium","volume":"2010","author":"JY Byun","year":"2010","journal-title":"Mediators Inflamm"},{"key":"pone.0240216.ref032","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archotol.134.3.306","article-title":"Identification of Id1 in acquired middle ear cholesteatoma","volume":"134","author":"QA Zhang","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T17:57:06Z","timestamp":1602179826000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240216"}},"subtitle":[],"editor":[{"given":"Ramin","family":"Massoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240216","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}